Alnylam Pharmaceuticals reported $369.31M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 146.91M 12.02M
Agios Pharmaceuticals AGIO:US $ 89.16M 66K
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Amgen AMGN:US $ 4.33B 1.37B
Arena Pharmaceuticals ARNA:US $ 194.48M 50.09M
Arrowhead Research ARWR:US $ 103.17M 25.41M
Avrobio Inc AVRO:US 32.62M 1.24M
Biocryst Pharmaceuticals BCRX:US $ 85.58M 6.04M
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Bluebird Bio BLUE:US $ 239.63M 8.68M
Dicerna Pharmaceuticals DRNA:US $ 83.23M 1.64M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Intercept Pharmaceuticals ICPT:US $ 82.54M 13.28M
IONIS PHARMACEUT IONS:US $ 219M 11.65M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Moderna Inc MRNA:US 1.41B 119M
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Novartis NVS:US 10.13B 319M
Ptc Therapeutics PTCT:US $ 231.82M 16.65M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M
Regulus Therapeutics RGLS:US $ 8.42M 1.78M
Sangamo Biosciences SGMO:US $ 77M 427K
Sarepta Therapeutics SRPT:US $ 228.35M 103.31M
Takeda 4502:JP 747.39B 46.34B
Ultragenyx Pharmaceutical RARE:US $ 171.48M 1.72M
Vertex Pharmaceuticals VRTX:US $ 929.65M 901.68M
Xencor XNCR:US $ 61.58M 3.22M
YTE INCY:US $ 577.58M 12.7M